Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-1-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.
???displayArticle.pubmedLink???
10364157 ???displayArticle.pmcLink???PMC316770 ???displayArticle.link???Genes Dev ???displayArticle.grants???[+]
Andrews,
The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene.
1993, Pubmed
Andrews,
The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene.
1993,
Pubmed Andrews,
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.
1991,
Pubmed Ben-David,
Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
1991,
Pubmed Ben-David,
Friend virus-induced erythroleukemia and the multistage nature of cancer.
1991,
Pubmed Blobel,
Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor.
1995,
Pubmed Blobel,
CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation.
1998,
Pubmed Borràs,
Repression of I-A beta gene expression by the transcription factor PU.1.
1995,
Pubmed Briegel,
Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner.
1993,
Pubmed Cheng,
Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells.
1996,
Pubmed Cross,
The lineage commitment of haemopoietic progenitor cells.
1997,
Pubmed Delgado,
Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
1998,
Pubmed Evans,
trans-Activation of a globin promoter in nonerythroid cells.
1991,
Pubmed Fisher,
Role of PU.1 in hematopoiesis.
1998,
Pubmed Galson,
Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.
1993,
Pubmed Gauthier,
Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors.
1993,
Pubmed Goebl,
The PU.1 transcription factor is the product of the putative oncogene Spi-1.
1990,
Pubmed Haenlin,
Transcriptional activity of pannier is regulated negatively by heterodimerization of the GATA DNA-binding domain with a cofactor encoded by the u-shaped gene of Drosophila.
1997,
Pubmed Hagemeier,
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
1993,
Pubmed Hallier,
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS.
1998,
Pubmed Hallier,
The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb.
1996,
Pubmed Henkel,
PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.
1994,
Pubmed Hromas,
Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1.
1993,
Pubmed Hunter,
Oncoprotein networks.
1997,
Pubmed Klemsz,
Activation of transcription by PU.1 requires both acidic and glutamine domains.
1996,
Pubmed Klemsz,
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.
1990,
Pubmed Krieg,
In vitro RNA synthesis with SP6 RNA polymerase.
1987,
Pubmed Leonard,
Expression of the chicken GATA factor family during early erythroid development and differentiation.
1993,
Pubmed Look,
Oncogenic transcription factors in the human acute leukemias.
1997,
Pubmed López-Rodríguez,
PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site.
1997,
Pubmed Lu,
Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression.
1994,
Pubmed Marks,
Induction of transformed cells to terminal differentiation and the modulation of gene expression.
1987,
Pubmed Martin,
Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.
1990,
Pubmed McKercher,
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.
1996,
Pubmed Merika,
Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF.
1995,
Pubmed Miller,
A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins.
1993,
Pubmed Moreau-Gachelin,
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.
1988,
Pubmed Moreau-Gachelin,
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.
1996,
Pubmed Moreau-Gachelin,
Spi-1/PU.1: an oncogene of the Ets family.
1994,
Pubmed Moreau-Gachelin,
The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.
1989,
Pubmed Nagulapalli,
Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3).
1995,
Pubmed Nemoto,
Regulatory function of delta/YY-1 on the locus control region-like sequence of mouse glycophorin gene in erythroleukemia cells.
1996,
Pubmed Nerlov,
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
1998,
Pubmed Osada,
Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.
1995,
Pubmed Paul,
A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.
1989,
Pubmed Petrovick,
Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.
1998,
Pubmed Quang,
Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors.
1995,
Pubmed Rao,
Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
1997,
Pubmed Ray,
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.
1992,
Pubmed Reddy,
Erythroid differentiation of mouse erythroleukemia cells results in reorganization of protein-DNA complexes in the mouse beta maj globin promoter but not its distal enhancer.
1993,
Pubmed Schuetze,
The Ets-related transcription factor PU.1 immortalizes erythroblasts.
1993,
Pubmed Schuetze,
Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.
1992,
Pubmed Scott,
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.
1994,
Pubmed Shivdasani,
The transcriptional control of hematopoiesis.
1996,
Pubmed Sif,
Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.
1994,
Pubmed Starck,
Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
1999,
Pubmed
,
Xenbase Strauss,
In vivo footprinting of the human alpha-globin locus upstream regulatory element by guanine and adenine ligation-mediated polymerase chain reaction.
1992,
Pubmed Tenen,
Transcription factors, normal myeloid development, and leukemia.
1997,
Pubmed Tsai,
Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.
1989,
Pubmed Tsai,
An early haematopoietic defect in mice lacking the transcription factor GATA-2.
1994,
Pubmed Tsang,
FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.
1997,
Pubmed Watanabe,
Induction of cyclin D1 by simian virus 40 small tumor antigen.
1996,
Pubmed Weintraub,
Mechanism of active transcriptional repression by the retinoblastoma protein.
1995,
Pubmed Yamada,
Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
1997,
Pubmed
